Jeff Taylor

411 total citations
5 papers, 325 citations indexed

About

Jeff Taylor is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Rheumatology. According to data from OpenAlex, Jeff Taylor has authored 5 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 2 papers in Internal Medicine and 2 papers in Rheumatology. Recurrent topics in Jeff Taylor's work include Atrial Fibrillation Management and Outcomes (3 papers), Systemic Lupus Erythematosus Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Jeff Taylor is often cited by papers focused on Atrial Fibrillation Management and Outcomes (3 papers), Systemic Lupus Erythematosus Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Jeff Taylor collaborates with scholars based in United States, Norway and New Zealand. Jeff Taylor's co-authors include Robert C. Gosselin, E. M. Hawes, Stephan Moll, Allison M. Deal, Anne Winkler, Abigail Cook, Herbert C. Whinna, Douglas A. Triplett, Finn Wislöff and Eva‐Marie Jacobsen and has published in prestigious journals such as Journal of Thrombosis and Haemostasis, Thrombosis Research and Archives of Pathology & Laboratory Medicine.

In The Last Decade

Jeff Taylor

5 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Taylor United States 5 239 178 60 55 39 5 325
Youngsook Choi United States 7 195 0.8× 91 0.5× 23 0.4× 25 0.5× 23 0.6× 16 279
Fenny Berends Netherlands 6 74 0.3× 80 0.4× 97 1.6× 18 0.3× 104 2.7× 7 329
Sara Biere‐Rafi Netherlands 7 112 0.5× 118 0.7× 181 3.0× 8 0.1× 79 2.0× 12 323
Esmeralda Filippucci Italy 7 225 0.9× 282 1.6× 123 2.0× 7 0.1× 95 2.4× 12 365
Isabelle Vernier France 7 287 1.2× 97 0.5× 29 0.5× 5 0.1× 144 3.7× 22 409
Danielle T. Vlazny United States 11 192 0.8× 226 1.3× 21 0.3× 7 0.1× 77 2.0× 31 312
Şenol Demircan Türkiye 11 195 0.8× 34 0.2× 7 0.1× 19 0.3× 72 1.8× 22 307
Marianna Leopoulou Greece 6 96 0.4× 78 0.4× 11 0.2× 5 0.1× 87 2.2× 14 265
Y. Gruel France 6 46 0.2× 44 0.2× 184 3.1× 18 0.3× 27 0.7× 13 245
Şaban Keleşoğlu Türkiye 12 212 0.9× 51 0.3× 5 0.1× 11 0.2× 51 1.3× 43 364

Countries citing papers authored by Jeff Taylor

Since Specialization
Citations

This map shows the geographic impact of Jeff Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Taylor more than expected).

Fields of papers citing papers by Jeff Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Taylor. The network helps show where Jeff Taylor may publish in the future.

Co-authorship network of co-authors of Jeff Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Taylor. A scholar is included among the top collaborators of Jeff Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Taylor. Jeff Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Gosselin, Robert C., Dorothy M. Funk, Jeff Taylor, et al.. (2014). Comparison of Anti-Xa and Dilute Russell Viper Venom Time Assays in Quantifying Drug Levels in Patients on Therapeutic Doses of Rivaroxaban. Archives of Pathology & Laboratory Medicine. 138(12). 1680–1684. 39 indexed citations
2.
Jayathissa, Sisira, et al.. (2014). Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice. Internal Medicine Journal. 44(3). 261–265. 28 indexed citations
3.
Hawes, E. M., Allison M. Deal, Robert C. Gosselin, et al.. (2013). Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross‐sectional pharmacodynamic study based on peak and trough plasma levels. Journal of Thrombosis and Haemostasis. 11(8). 1493–1502. 202 indexed citations
4.
Jacobsen, E., et al.. (2001). The Evaluation of Clotting Times in the Laboratory Detection of Lupus Anticoagulants. Thrombosis Research. 104(4). 275–282. 20 indexed citations
5.
Jacobsen, Eva‐Marie, et al.. (2000). The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.. PubMed. 83(5). 704–8. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026